Targeting inflammation may help overcome drug resistance in colon cancer
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, ...
May 21, 2026
0
4









